Compare CHCO & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CHCO | PLSE |
|---|---|---|
| Founded | 1957 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1995 | 2015 |
| Metric | CHCO | PLSE |
|---|---|---|
| Price | $122.03 | $23.04 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $132.50 | $22.00 |
| AVG Volume (30 Days) | 121.3K | ★ 225.8K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | ★ 13.18 | N/A |
| EPS | ★ 8.93 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.16 | $840.00 |
| Revenue Next Year | $3.12 | $287.54 |
| P/E Ratio | $13.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $102.22 | $12.56 |
| 52 Week High | $133.59 | $26.30 |
| Indicator | CHCO | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 57.38 | 60.50 |
| Support Level | $120.12 | $13.75 |
| Resistance Level | $124.79 | $23.18 |
| Average True Range (ATR) | 2.64 | 1.38 |
| MACD | 0.54 | 0.04 |
| Stochastic Oscillator | 97.67 | 84.78 |
City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.